Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-07-06

Clinical Trial Update: Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome? [Phase 3]

View source ↗

Summary

A Phase 3 Cairo University trial is investigating whether adding oral contraceptives to fluoxetine improves management of Premenstrual Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine (Fluoxetine)
  • Oral contraceptives (combined oral contraceptives)

Snippet

Sponsor: Cairo University | Conditions: Premenstrual Syndrome | Phase 3 | Status: UNKNOWN